These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10582139)

  • 1. Vinorelbine (navelbine) in the treatment of non-small-cell lung cancer: recent developments in combination chemotherapy and radiotherapy.
    Gralla R; Harper P; Johnson S; Delgado FM
    Ann Oncol; 1999; 10 Suppl 5():S47-51. PubMed ID: 10582139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial.
    Krzakowski M; Provencio M; Utracka-Hutka B; Villa E; Codes M; Kuten A; Henke M; Lopez M; Bell D; Biti G; Merimsky O; Beorchia A; Riggi M; Caux NR; Pouget JC; Dubray B; David P
    J Thorac Oncol; 2008 Sep; 3(9):994-1002. PubMed ID: 18758302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
    Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
    Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
    Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin and vinorelbine followed by radiotherapy in the treatment of stage III-B non-small-cell lung cancer patients.
    Felip E; Del Campo JM; Bodi R; Vera R; Casado S; Rubio D
    Am J Clin Oncol; 1997 Aug; 20(4):404-6. PubMed ID: 9256899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant brain radiotherapy and vinorelbine-ifosfamide-cisplatin chemotherapy in brain metastases of non-small cell lung cancer.
    Quantin X; Khial F; Reme-Saumon M; Michel FB; Pujol JL
    Lung Cancer; 1999 Oct; 26(1):35-9. PubMed ID: 10574679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral vinorelbine and cisplatin with concomitant radiotherapy in stage III non-small cell lung cancer (NSCLC): a feasibility study.
    Beckmann G; Fietkau R; Huber RM; Kleine P; Schmidt M; Semrau S; Aubert D; Fittipaldo A; Flentje M
    Onkologie; 2006 Apr; 29(4):137-42. PubMed ID: 16601369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vinorelbine, ifosfamide, and cisplatin combination chemotherapy in advanced non-small-cell lung cancer.
    Ahn JB; Ko WK; Lee JG; Shim KY; Jeung HC; Park JO; Yoo NC; Kim BS; Kim SK; Kim SK; Kim JH
    Am J Clin Oncol; 2000 Dec; 23(6):622-8. PubMed ID: 11202811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1.
    Robinet G; Thomas P; Breton JL; Léna H; Gouva S; Dabouis G; Bennouna J; Souquet PJ; Balmes P; Thiberville L; Fournel P; Quoix E; Riou R; Rebattu P; Pérol M; Paillotin D; Mornex F
    Ann Oncol; 2001 Jan; 12(1):59-67. PubMed ID: 11249050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer. A phase II trial conducted by the Groupe Francais de Pneumo-Cancerologie (GFPC).
    Vergnenègre A; Daniel C; Léna H; Fournel P; Kleisbauer JP; Le Caer H; Letreut J; Paillotin D; Pérol M; Bouchaert E; Preux PM; Robinet G;
    Lung Cancer; 2005 Mar; 47(3):395-404. PubMed ID: 15713523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E; Silvano G; Tibaldi C; Campoccia S; Cionini L; Conte P
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of unresectable non-small-cell lung cancer].
    Ueoka H
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):356-61. PubMed ID: 10740628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vinorelbine (Navelbine) in non-small cell lung cancer: future directions.
    Crawford J
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):85-8. PubMed ID: 7526468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vinorelbine, ifosfamide, and cisplatin combination as salvage chemotherapy in advanced non-small cell lung cancer.
    Song SY; Kim WS; Kim K; Jung CW; Im YH; Kim HJ; Kang WK; Lee HG; Kwon OJ; Rhee CH; Park CH; Park K
    Jpn J Clin Oncol; 2003 Oct; 33(10):509-13. PubMed ID: 14623918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction chemotherapy followed by concomitant chemoradiotherapy for non-small cell lung cancer.
    Vokes EE
    Oncologist; 2001; 6 Suppl 1():25-7. PubMed ID: 11182002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ifosfamide in non-small cell lung cancer.
    Boni C; Zanelli F
    Oncology; 2003; 65 Suppl 2():50-4. PubMed ID: 14586148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
    Rusu P; Ciuleanu TE; Cernea D; Pelau D; Gaal V; Cebotaru C; Guttman T; Todor N; Ghilezan N
    J BUON; 2007; 12(1):33-9. PubMed ID: 17436399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vinorelbine (Navelbine) in the adjuvant and neoadjuvant treatment of non-small cell lung cancer.
    Viallet J; Ayoub J; Rousseau P; Souhami L; Hohneker J; Shepherd F
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):64-71; discussion 71-2. PubMed ID: 7973771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP).
    Baldini E; Tibaldi C; Ardizzoni A; Salvati F; Antilli A; Portalone L; Barbera S; Romano F; De Marinis F; Migliorino MR; Noseda MA; Borghini U; Crippa M; Ferrara G; Raimondi M; Fioretti M; Bandera M; Pennucci MC; Galeasso G; Cacciani GC; Lepidini G; Sunseri G; Lanfranco C; Rinaldi M; Rosso R
    Br J Cancer; 1998 Jun; 77(12):2367-70. PubMed ID: 9649160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.